L. Shi et al.
1H NMR (300 MHz, DMSO-d6): d 7.17 (m, 5H), 6.74 (d, 1H), 3.50 (2 Â 30 mL). The combined methyl isobutyl ketone extracts
(m, 1H), 3.36 (m, 1H), 2.98 (d, 1H), 2.60–2.40 (m, 2H), 2.30 (d, 2H), were washed with brine, dried over Na2SO4, and concentrated
1.64 (m, 1H), 1.26–1.10 (d, 9H), 0.87 (d, 6H).
under reduced pressure to afford (18) as a yellow foam (1.0 g,
84.7%).
Synthesis of (2S,3R)-N-(3-amino-2-hydroxy-4-phenyl)-N-
isobutyl-4-[2H4]-nitrobenzene sulphonamide hydrochloride
(16)
Synthesis of (3S)-tetrahydro-3-furanyl-(1S,2R)-3-[[(4-[2H4]-
aminophenyl)-sulfonyl](isobutyl)amino]-1-benzyl-2-
(phosphonooxy)propylcarbamate (19)
To a solution of (15) (1.27 g, 3.8 mmol) in toluene (9 mL) heated
to 801C was added triethylamine (0.42 g, 4.2 mmol). The mixture To a solution of (18) (0.3 g, 0.5 mmol) in MeOH (7.5 mL) was
was heated to 901C and a solution of (7) (1.0 g, 4.5 mmol) in added 10% palladium on charcoal (0.15 g). The slurry was stirred
toluene (4 mL) was added and stirred for 2 h. The reaction under hydrogen at room temperature for 5 h. The catalyst was
mixture was then cooled to 801C and then concentrated removed by filtration and washed with methanol. After
hydrochloric acid (0.4 mL, 4.8 mmol) was added slowly. The concentration, it gave (19) as a yellow foam (0.27 g, 91.5%).
mixture was heated to reflux (approx 881C) for 1 h. Another
portion of concentrated hydrochloric acid (0.3 mL, 3.6 mmol) Synthesis of [2H4]-fosamprenavir calcium (20)
was added. Solvent was removed from the reaction mixture by
To a suspension of (19) (0.5 g, 0.9 mmol) in MeOH (10 mL) was
using the rotary evaporator. EtOAc (6 mL) was added. The
added a solution of calcium acetate monohydrate (0.27 g,
1.7 mmol) in water (2 mL). The reaction mixture was stirred at
bath. The product was isolated by filtration, washed with cold
mixture was stirred at 601C for 30 min, and then cooled in an ice
room temperature for 15 min and then treated slowly with 5%
EtOAc (3 mL), and dried under vacuum to afford (16) as a white
NaOH until pH 8–9. Product started to precipitate. It was filtered,
solid (1.4 g, 80.5%).
washed with EtOH/H2O (6 mL, 1:1), and then dried in vacuo at
35–401C to afford desired product (20) as a white solid (0.34 g,
64.2%).
1H NMR (300 MHz, Solvent 0.1N DCl in D2O): d 7.36–7.28 (m,
5H), 4.96–4.79 (m, 1H masked by HOD signal), 4.49 (m, 1H),
Synthesis of (2S,3R)-N-(3-amino-2-hydroxy-4-phenyl)-N-
isobutyl-4-[2H4]-nitrobenzene sulphonamide hydrochloride
(17)
To a solution of bis(trichloromethyl)carbonate (0.56 g, 1.9 mmol)
in dichloromethane (15 mL) cooled in an ice-salt bath was added
dropwise (S)-3-hydroxytetrahydrofuran (0.5 g, 5.7 mmol) and
triethylamine (0.57 g, 5.7 mmol). The reaction mixture was stirred
at room temperature for 3 h. TLC analysis showed that the
reaction was complete. The reaction mixture was evaporated to
dryness under nitrogen. The white residue was dissolved in
dichloromethane (50 mL). Amine hydrochloride (2.3 g, 5 mmol)
was added dropwise. The suspension was cooled in ice-water.
Triethylamine (1.4 g, 14 mmol) was added dropwise. The
reaction mixture was stirred at room temperature for 1 h. TLC
analysis showed that the reaction was complete. The reaction
mixture was evaporated to dryness. Water (30 mL) was added.
The reaction mixture was extracted with dichloromethane
(3 Â 25 mL). The combined dichloromethane extracts were
washed with brine, dried over Na2SO4, and concentrated under
reduced pressure to afford a white solid which was recrystallized
from EtOAc/EtOH (16 mL, 4:1), to afford (17) as a white solid
(2.2 g, 82.1%).
4.29–4.16 (m, 1H), 3.89–3.55 (m, 4H), 3.42–3.33 (m, 2H), 3.16–2.90
(m, 3H), 2.75–2.60 (m, 1H), 2.11–1.85 (m, 2.5H), 1.30–1.15 (m,
0.5H), 0.85–0.79 (m, 6H). MS-EI (m/z): 587.1 (7), 588.1 (MÀ, 100),
589.1 (30), 590.1 (10). HPLC (XDB-C18, CH3OH/10 mmol/L
NaH2PO410.1% H3PO4 = 50/50, 1.0 mL/min): tR 5.8 min (498.5%).
MS-EI analysis of compound (20) revealed that the compound has
98.2% deuterium enrichment, which is about the same as
compound (6).
References
[1] N. E. Kohl, E. A. Emini, W. A. Schleif, L. J. Davis, J. C. Heimbach,
R. A. F. Dixon, E. M. Scolnick, I. S. Sigal, Proc. Nat. Acad. Sci., U.S.A.
1988, 85, 4686–4690.
[2] H. G. Gottlinger, J. G. Sodroski, W. A. Haseltine, Proc. Nat. Acad.
Sci., U.S.A. 1989, 86, 5781–5785.
[3] C. Peng, B. K. Ho, T. W. Chang, N. T. Chang, J. Virol. 1989, 63,
2550–2556.
[4] T. J. McQuade, A. G. Tomasselli, L. Liu, V. Karacostas, B. Moss,
T. K. Sawyer, R. L. Heinrikson, W. G. Tarpley, Science 1990, 247,
454–456.
[5] L. A. Sorbera, L. Martin, J. Castaner, R. M. Castaner, Drugs Future
2001, 26, 224–231.
Synthesis of (3S)-tetrahydro-3-furanyl-(1S,2R)-3-[[(4-[2H4]-
nitrophenyl)-sulfonyl](isobutyl)amino]-1-benzyl-2-
(phosphonooxy)propylcarbamate (18)
[6] R. M. Stuart, patent WO 9948885, 1999.
[7] R. D. Tung, M. A. Murcko, R. G. Bhisetti, patent WO 9405639,
1994.
To a solution of (17) (1.0 g, 1.9 mmol) in dry pyridine (50 mL)
cooled in an ice bath was added dropwise phosphorus
oxychloride (1.72 g, 11.2 mmol) under nitrogen. The reaction
mixture was stirred at room temperature for 2.5 h, and then
cooled in an ice bath. Water (20 mL) was added and extracted
with methyl isobutyl ketone (3 Â 30 mL). The combined organic
layers were dried over Na2SO4. Concentration under reduced
pressure afforded a yellow solid. The yellow residue was
dissolved in methyl isobutyl ketone (50 mL) followed by the
dropwise addition of 6 M HCl (2 mL). After stirring at 501C for
2.5 h, water (20 mL) was added. Layers were separated and the
aqueous layer was extracted with methyl isobutyl ketone
[8] R. D. Tung, patent WO 9633184, 1996.
[9] S. Smiles, J. Stewart, Org. Syn. Coll. 1941, 1, 8.
[10] R. Winkler, M. E. A. Richter, U. Knu¨pfer, D. Merten, C. Hertweck,
Angew. Chem. Int. Ed. 2006, 45, 8016–8018.
[11] J. V. Bhaskar Kanth, M. Periasamy, J. Org. Chem. 1991, 56,
5964–5965.
[12] Y. Hamada, T. Shioiri, Chem. Pharm. Bull. 1982, 30, 1921–1924.
[13] P. L. Beaulieu, D. Wernic, J. S. Duceppe, Y. Guindon, Tetrahedron
Lett. 1995, 36, 3317–3320.
[14] P. L. Beaulieu, D. Wernic, J. Org. Chem. 1996, 61, 3635–3645.
[15] I. G. A. Arlesey, A. D. S. Stevenage, H. S. Dartford, patent US
6514953B1, 2003.
J. Label Compd. Radiopharm 2010, 53 147–151
Copyright r 2010 John Wiley & Sons, Ltd.